The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or assessing molecular and cellular features of cancer biology. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.
Source: National Cancer Institute
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular analysis technologies. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.
Source: National Cancer Institute
The NIH’s National Cancer Institute will fund up to $325,000 per year for projects developing new technical capabilities for cancer research and clinical oncology. This funding opportunity lines up with the Blue Ribbon Panel (BRP) of the Beau Biden Cancer MoonshotSM Initiative goals. Priority areas include a focus on experimental and analytical capabilities addressing cancer development; technologies advancing precise cancer diagnoses; new predictive models; and new technologies/approaches to improve biospecimen and data quality.
The Sharing Partnership for Innovative Research in Translation (SPIRiT), a CTSA consortium, has a new funding program in part funded by the ITM that supports pilot research projects between investigators from SPIRiT sites, including Johns Hopkins University, University of Chicago, University of Pennsylvania, University of Pittsburgh, Washington University in St. Louis, and Yale University (all ITM National CTSA partners). Projects can secure up to $25,000 per site for research that represents a new collaboration between investigators from at least two SPIRiT sites or a new project conducted by existing collaborators from at least two SPIRiT sites. Proposed projects may address any aspect of clinical and translational science.
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience or translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral mechanisms that begin in childhood and adolescence.
UChicago students, faculty, staff and alums can apply for the chance to win $10,000 to build an app. Submit your good idea, and UChicago, in partnership with IT Services and the Polsky Center, will do the programming to build it–no tech skills required to apply!
Join the ranks of ITM investigators, like Daniel Rubin, who are developing world-changing apps with the help of the App Challenge’s funding and programming support.
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy human life span. This includes identification of specific populations particularly likely to benefit from treatment, and/or obtaining information on metformin’s effects that would be useful in identifying novel molecular targets.
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer’s Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD research.
Source: National Institute on Aging